NGEN.V missed EPS expectations by 51.34%
Apr 08, 2025, 10:33 AM
0.00%
NervGen Pharma Corp (NGEN.V) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, NervGen Pharma Corp's actual EPS was -$0.13, missing the estimate of -$0.09 per share, resulting in a -51.34% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.